As part of FDA's Safe Use Initiative:
Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm.

The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of

credit:

How's Your Community Doing?
Check Out it's
Community Vital Signs

regulated prescription and over the counter medications.

The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety.

This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm.